Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00412-5/abstract?utm_campaign=update-lanres&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanres&_hsenc=p2ANqtz-_jVWb3uuNNPqTYkHBN0m2IiHdOPgZBEfoQAzPU11YPt7Z-cH7Bp9h2LmLseBEWCKKzCs2Pg4NdJTG-VqRfnCpryOAEHg&_hsmi=301724902&utm_content=301650997&utm_source=hs_email